In the present study, the contribution of CD4+ and CD8+ T lymphocytes to acquired immunity to blood-stage infection with the murine malaria species Plasmodium chabaudi AS was investigated. C57BL/6 mice, which are genetically resistant to infection with this hemoprotozoan parasite and exhibit a transient course of infection, were treated intraperitoneally with monoclonal antibodies to T-cell epitopes, either anti-Thy-1, anti-CD4, or anti-CD8. After intraperitoneal infection with 106 parasitized erythrocytes, control C57BL/6 mice exhibited a peak parasitemia on day 9 of approximately 35% parasitized erythrocytes and eliminated the infection within 4 weeks. Mice depleted of Thy-1+ or CD4+ T cells had significantly higher parasitemias on day 7 as well as significantly higher peak parasitemias. These mice were unable to control the infection and developed a persistent, high parasitemia that fluctuated between 40 and 60% until the experiment was terminated on day 56 postinfection. Depletion of CD8+ T lymphocytes was found to have no effect on the early course of parasitemia or on the level of peak parasitemia. However, mice depleted of CD8+ T cells experienced two recurrent bouts of parasitemia during the later stage of the infection and required more than 5 weeks to eliminate the parasites. After the peak parasitemia, which occurred in control and experimental animals on day 9, there was a sharp drop in parasitemia coinciding with a wave of reticulocytosis. Therefore, the contribution of the influx of reticulocytes, which are not the preferred host cell of this hemoprotozoan parasite, to limiting the parasitemia was also examined by determining the course of reticulocytosis during infection in control and T cell-depleted animals. Early in infection, there was a marked and comparable reticulocytosis in the peripheral blood of control and T cell-depleted mice; the reticulocytosis peaked on day 12 and coincided with the dramatic and sudden reduction in parasitemia occurring in all groups. In both control and CD8-depleted mice the percentage of reticulocytes decreased as the infection was resolved, whereas in CD4-depleted mice marked reticulocytosis correlated with high, persistent parasitemia. These results thus demonstrate that both CD4+ and CD8+ T cells are involved in acquired immunity to blood-stage P. chabaudi AS and that the influx of reticulocytes into the blood that occurs just after the peak parasitemia may contribute temporarily to limiting the parasitemia.
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Evidence has accumulated to suggest that both humoral and cell-mediated mechanisms are involved in acquired immunity to blood-stage malaria. Protective immunity to the blood stage of Plasmodium berghei and P. yoelii, which appears to occur by an antibody-dependent mechanism, fails to develop in athymic nude mice (7, 40) . Adoptive transfer studies have confirmed the importance of T cells in the development of immunity to these parasites (3, 4, 12, 18) . Helper T cells aiding B cells to produce antimalarial antibodies appear to be the mechanism of T cell-dependent immunity to P. yoelii and P. berghei (16) . Studies have shown that antibody-independent mechanisms of immunity also exist for some murine malaria parasites. Grun and Weidanz (14) were the first to demonstrate such a mechanism for Plasmodium chabaudi adami. This observation has recently been extended to include Plasmodium vinckei petteri, P. chabaudi CB, and a related hemoprotozoan parasite, Babesia microti (6) , as well as P. chabaudi AS, the parasite used in the present study (36a) .
Although CD8+ T lymphocytes are clearly involved in protecting mice during the sporozoite stage of infection with P. berghei and P. yoelii (30, 41) , their role during the erythrocytic stage of malaria is less clear. In the model of * Corresponding author.
blood-stage P. chabaudi adami infection, protection was found to be transferred most efficiently to recipient nude mice by CD4+-enriched immune spleen cells; CD8+-enriched T cells also were found to transfer protection, albeit to a lesser extent (5) . Mogil and her colleagues (23) demonstrated that adoptive transfer of CD8+ T cells from P. yoelii-immune animals into naive mice accelerated recovery, whereas Vinetz and his colleagues (39) were unable to demonstrate a protective effect of CD8+ T cells. Recent evidence suggests that CD4+ T cells but not CD8+ T cells are required for the development of immunity to P. chabaudi AS (37).
In the experiments described here, we examined the contribution of CD4-and CD8-bearing T cells to acquired immunity to blood-stage P. chabaudi AS. C57BL/6 mice treated with monoclonal antibodies (MAbs) to specifically deplete T-cell subsets in vivo were observed for aberrations in the course of infection with P. chabaudi AS. These studies, which were in progress when the results of Suss et al. (37) evidence that the influx of reticulocytes into the blood that occurs just after the peak parasitemia may contribute temporarily to limiting the parasitemia.
MATERIALS AND METHODS
Mice. Female C57BL/6NCrlBR (C57BL/6) mice 6 to 8 weeks of age were purchased from Charles River, Inc., St. Constant, Quebec. Male nude mice (Hsd: nulnu) 6 weeks old were purchased from Harlan Sprague Dawley, Inc., Indianapolis, Ind. BALB/c mice were bred in our facility.
Parasite. The AS strain of P. chabaudi was obtained from D. Walliker (University of Edinburgh, Edinburgh, Scotland). Aliquots of parasitized blood were stored in liquid nitrogen. Parasites were kept viable by weekly passage in C57BL/6 mice. After 12 consecutive passages, a fresh inoculum was prepared from the frozen stock. For passage or infection, blood was collected from two C57BL/6 mice by bleeding via the retroorbital plexus and pooled. Total erythrocyte (RBC) counts were determined. The percent parasitemia was determined by counting the percentage of parasitized RBC (PRBC) per 100 RBC on duplicate, Dif-Quik (American Scientific Products, McGaw Park, Ill.)-stained thin blood smears. RBC, diluted in sterile phosphate-buffered saline, were adjusted to the desired concentration of parasitized RBC and injected intraperitoneally (i.p.) into passage or experimental mice. Infection was initiated with a dose of 107 PRBC for passage mice and 106 PRBC for experimental mice.
Determination of parasitemia. Blood samples were collected from experimental mice by bleeding via the tail vein at the times indicated. Duplicate thin blood smears were prepared and stained with Dif-Quik. Parasitemias were determined by counting the percentage of infected cells per 100 RBC per slide. The parasitemia is expressed as mean percent PRBC + the standard error of the mean (SEM) for each group of mice.
Determination of percentage of reticulocytes. A total of 200 RBC per duplicate Dif-Quik-stained thin blood smears was examined to determine the percentage of reticulocytes present in the peripheral blood. Reticulocytes were distinguished on the basis of size and staining characteristics. The results are expressed as the mean percent reticulocytes + SEM for each group of mice.
MAbs. Three hybridomas were used to obtain rat antimouse MAbs. Both GK1.5 (anti-CD4; rat immunoglobulin G2b [IgG2b]) and 30-H12 (anti-Thy-1.2; rat IgG2b) hybridomas were kindly provided by T. Owens, Centre for the Study of Host Resistance, McGill University, Montreal, Quebec (10, 22) . The hybridoma line 2.43 (anti-CD8; rat IgG2b) was purchased from the American Type Culture Collection, Rockville, Md. (29) . MAbs from the hybridoma lines 30-H12 and 2.43 were obtained as ascites fluids from pristane-primed nude mice injected i.p. with the relevant hybridoma. Anti-CD4 MAb was obtained as ascites fluid from sublethally irradiated, pristane-primed BALB/c mice injected i.p. with the hybridoma. Ascites fluids were delipified by centrifugation, and aliquots were frozen at -20°C until required. The concentration of antibody was determined from pooled ascites fluid by using an enzyme-linked immunosorbent assay with specificity for rat IgG and calculated by using a commercially available standard (Becton Dickinson, Mississauga, Ontario).
In vivo treatment with MAbs. Aliquots of MAbs were thawed and diluted in phosphate-buffered saline to the desired concentration. Twenty C57BL/6 mice in one experiment and 32 mice in a second experiment were divided into four equal groups. Each group was treated with either anti-Thy-1 MAb, anti-CD4 MAb, anti-CD8 MAb, or normal rat serum. Mice were given one pretreatment of 500 ,ug of the appropriate anti-T-cell MAb injected i.p. 4 days before infection with 106 PRBC. Unless otherwise indicated, mice were treated i.p. with 200 ,ug of MAb every 3 days beginning on the day of infection (day 0) until the experiment was terminated on day 56 postinfection. Control mice were treated with normal rat serum containing a concentration of IgG equivalent to that of the MAb preparations administered according to the schedule used for the experimental groups. In one experiment, one mouse per group was sacrificed on day 34 postinfection, and in the other experiment, one mouse per group was sacrificed on the day of infection (day 0) and on days 9 and 56; the spleens were removed and prepared for fluorocytometric analysis.
Spleen cell preparation. Spleens were aseptically removed and perfused with 10 ml of RPMI 1640 (Flow Laboratories, Inc., Mississauga, Ontario) supplemented with 5% heatinactivated fetal calf serum (Hyclone Laboratories, Inc., Logan, Utah), 2% HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) buffer (Flow), and 0.12% gentamicin.
Cell suspensions were centrifuged at 350 x g for 10 min.
RBC were lysed with cold NH4Cl (0.17 M), and the cells were washed two times in fresh medium. Membrane debris was removed by filtering the cell suspension through sterile gauze. The viability was determined by trypan blue exclusion and was always greater than 90%.
Fluorocytometric analysis. Spleen cell suspensions were diluted to a concentration of 2 x 106 cells per ml. Aliquots of 0.5 ml were transferred to microtubes and centrifuged for 6 s at 13,000 rpm in a Microcentrifuge (Accurate Chemical and Scientific Corp. Functional studies. Normal, uninfected mice were treated with MAbs or normal rat serum according to the treatment schedule described above and were sacrificed 1 day after receiving the fourth injection of antibody. T-cell function was measured by the following in vitro assays.
(i) Th cells. The presence of CD4+ T cells in splenic lymphocytes was determined by their ability to help B cells make a primary antibody response in vivo to the T celldependent antigen sheep RBC (SRBC). Mice were immunized by intravenous injection with 0.3 ml of a 30% suspension of SRBC (approximately 5 x 108 cells), which were obtained as a 50% sterile suspension in Alsever solution (Institut Armand Frappier, Laval des Rapides, Quebec). Four days later, spleens were removed from immunized mice and weighed. Single-cell suspensions of splenic leukocytes were prepared as described above. Total and viable leukocyte counts were determined on individual spleen cell suspensions. The frequency of direct plaque-forming cells (PFC) was determined by using the slide method of Cunningham and Szenberg (9) . Briefly, 50-pd aliquots of spleen cell (Table 1) . Third, the cytotoxic activity of peritoneal exudate cells, mediated by the CD8+ subset of T cells, against the murine tumor cell line P815 was significantly decreased in mice depleted of CD8+ T cells by treatment with either anti-Thy-i or anti-CD8 MAbs (Fig. 2) .
Course of P. chabaudi AS infection in T cell-depleted mice. Control rat serum-treated C57BL/6 mice experienced a course of infection essentially identical to that of untreated animals (Fig. 3) . In each case, mice experienced a peak parasitemia of approximately 35% PRBC on day 9 postinfection. All the animals subsequently cleared the infection. By day 22, the parasitemia was reduced to less than 2%, and the infection was eliminated from the peripheral blood 4 weeks after initiation of the infection. No recrudescence of parasitemia was observed in these mice throughout the 56 days of the experiment.
To confirm the role of T cells in acquired immunity to P.
chabaudi AS, C57BL/6 mice were treated with anti-Thy-i
MAbs (data not shown). Depletion of T cells in normal, intact euthymic animals resulted in a course of infection similar to that exhibited by C57BL/6 nulnu mice (36a). There was a significant difference in the level of parasitemia between Thy-i-depleted mice and control mice as early as day 7 (34.6% + 2.5% and 25.5% + 1.9% PRBC, respectively; P < 0.01), and the peak parasitemia of Thy-l-depleted animals was significantly higher than that exhibited by control mice (58.7% + 3.4% and 35.4% + 1.6% PRBC, respectively; P < 0.001). Mice depleted of T cells by treatment with anti-Thy-i MAbs were unable to control the infection and suffered from a persistent, high parasitemia. There was 36.4% mortality (4 of 11 animals) among these animals. As described below, the high, persistent parasitemia in these animals coincided with a marked and sustained reticulocytosis. The prepatent and early patent periods of CD4-depleted mice were similar to those of control animals (Fig. 4) . In two separate experiments, mice depleted of CD4+ T cells had a significantly higher parasitemia on day 7 than did control animals. In the results of the experiment shown here, the parasitemia of CD4-depleted mice on day 7 was 37% ± 1.3% PRBC (P -0.001 in comparison with control mice). On day 9, the parasitemia had risen to a peak of 61.3% + 1.6% PRBC, a level significantly greater than the control parasitemia level of 35.4% + 1.6% PRlBC (P -0.001). Parasitemia declined in the CD4-depleted animals in a manner similar to that in control C57BL/6 mice; by day 12, parasitemia was 10%o ± 1.1%. The percentage of PRBC present in the peripheral blood of CD4-depleted mice, however, quickly rebounded to a level comparable to that of the peak parasitemia. The CD4-depleted mice were unable to control the infection and developed a high, persistent parasitemia that fluctuated between 40 and 6%o PRBC until the experiment was terminated on day 56. In contrast to Thy-i-depleted animals, CD4-depleted mice survived until the experiment was terminated despite suffering similar high, persistent parasitemia levels that coincided with sustained reticulocytosis. Similar results were obtained in a second experiment. In two separate experiments, depletiorn of CD8+ T cells had no effect on the course and level of parasitemia during the prepatent and patent periods or at the time of the peak parasitemia. The results of one of the experiments with 8 mice per group are shown in Fig. 5 . The elimination phase was initially identical to that in control animals. However, two recurrent bouts of parasitemia were consistently observed in both experiments in CD8-depleted mice. In the case of the experiment shown here, the first reached a peak of 17.9% ± 1.6% PRBC (P 5 0.001) on day 16. The parasitemia levels declined and remained at approximately 3% before a second smaller but still significant peak was observed on day 30 (8.5% ± 1.8% PRBC; P < 0.01). The plateau (3% PRBC) level between these two peaks was also found to be statistically significantly different from that of control mice, which at this time experienced a parasitemia of less than 1%. The CD8-depleted mice differed from control animals in the developmental stages of parasites present in the blood during the elimination phase. The parasites observed in control mice were generally crisis forms, whereas solved. However, two recurrent bouts of parasitemia were consistently observed during the elimination phase, which required more than 5 weeks instead of the 4 weeks characteristic of this infection in resistant C57BL/6 mice. This esent in the peripheral blood during the two observation demonstrates that CD8+ T cells also contribute rasitemia peaks of the CD8-depleted groups were to acquired immunity to this parasite. iding forms. Moreover, elimination of the parasite Our results confirm previous studies utilizing adoptive eted animals required more than 5 weeks instead transfer of purified and enriched T-cell populations that weeks characteristic of C57BL/6 mice. demonstrated the importance of CD4+ T lymphocytes in reticulocytosis in T cell-depleted mice. The conprotective immunity to P. yoelii (3, 18, 23, 39) and P. reticulocytosis to limiting the level of parasitchabaudi (5, 37) . Studies by Brake and his colleagues (2) infection with P. chabaudi AS, hemoprotozoan demonstrated that T-cell lines obtained from P. chabaudi hich preferentially invade mature erythrocytes, adami-infected mice and propagated in vitro can transfer gated by determining the percentage of reticulo-protection in vivo. These investigators have further shown nt in the peripheral blood during the course of that a CD4+ T-cell clone, which is specific for P. chabaudi control and T cell-depleted animals. Reticuloadami, can transfer protection to nude mice and can produce tound to represent approximately 5% of the total gamma interferon and interleukin-2 in response to specific 'BC in all experimental groups until day 10, when antigens (1). dramatic influx of reticulocytes (Fig. 6) . This
While the experiments described here were in progress, ided with severe anemia, and reticulocytes comSuss et al. (37) published results of similar experiments with oximately 30% of the total RBC in both the C57BL/6 mice infected with P. chabaudi AS. They conLl and control groups of mice. On day 12 of cluded that CD4+ T cells are the predominant lymphocyte hen the parasitemia levels had fallen to approxinvolved in the development of protective immunity to P.
O in control and experimental animals, the perchabaudi AS and that CD8+ T cells do not contribute eticulocytes was 50 to 60% in all groups. These significantly. Differences in the origin and virulence of the est that the influx of reticulocytes, which are not parasites and the size of the inoculum, as well as differences d host cell of this parasite (21) The role of CD4+ T cells in cell-mediated immunity against intracellular bacteria, fungi, and protozoa is generally accepted to be via the production of lymphokines that activate macrophages to express powerful antimicrobial activity. This mechanism has been hypothesized for the elimination of some plasmodium species, including P. chabaudi AS (33) . CD4+ T cells may also provide help to expand effector CD8+ T-cell populations via the production of interleukin-2. Interleukin-2 produced by CD4+ T cells has been demonstrated not only to enhance the effectiveness of cytotoxic T cells but also to induce the production of gamma interferon by these cells (11, 38 (23) . CD8+ T-cell clones isolated from individuals infected with P. falciparum have been demonstrated to respond to specific antigen in vitro (32) . Further studies have shown that these MHC-restricted P. falciparum-specific clones are capable of lysing unrelated tumor target cells when stimulated with anti-CD3 antibodies, suggesting that these cells possess cytotoxic potential (31) . In addition, unfractionated murine splenic lymphocytes, depleted of macrophages, have been shown to lyse P. berghei-infected erythrocytes, both in the presence and in the absence of immune serum (8, 26) .
Since mature RBC express little class I MHC, it is difficult to reconcile how cytotoxic T lymphocytes can exert a direct effect on parasitized erythrocytes. Although it is true that mature RBC do not express MHC antigens, it is clear in humans that reticulocytes express a significant number of these molecules (15, 20) . Studies by Jayawardena et al. (17) have shown that in mice there is increased expression of H-2K and H-2D molecules on P. yoelii-infected reticulocytes; these authors suggested that this may be a factor contributing to immunogenicity. In the same study, P. chabaudi-infected erythrocytes also showed a slight enhancement of class I MHC expression. Alternatively, CD8+ T cells may exert an antiplasmodial effect indirectly via the production of gamma interferon. This lymphokine is necessary for activating macrophages to express enhanced antimicrobial activity against both human and murine Plasmodium species in vitro and to destroy the intraerythrocytic parasite by the production of H202 (24, 25) .
A phenomenon of interest to us and one that was also observed by Sulss et al. (37) was the dramatic and sudden reduction in parasitemia that occurred immediately after the peak parasitemia in all experimental groups, including the control mice. In light of effective T-cell depletion, it seems unlikely that a specific T cell-dependent immune mechanism contributed to this sudden reduction. Nonspecific immune mechanisms may have contributed to this drop. Erythropoiesis in response to the malaria-induced anemia may account for this observation. Anemia was apparent in both the T cell-depleted and control mice on day 10 of infection. This resulted in a sudden influx of reticulocytes, which constituted approximately 30% of the total peripheral RBC. The rapid reduction in the number of mature erythrocytes, the host cells preferred by P. chabaudi AS, as a result of lysis of infected cells and the influx of reticulocytes may therefore account for the sharp drop in parasitemia. A similar conclusion was reached by Ott (28) on the basis of the observation that stimulation of reticulocytosis by injection of phenylhydrazine resulted in a diminished level of parasitemia during infection with P. chabaudi. Although P. chabaudi has a preference for the mature erythrocyte, it would appear that the parasite is not exclusively restricted to infecting this host cell type. The marked and sustained increase in the numbers of reticulocytes in Thy-i-or CD4-depleted mice resulted in infected reticulocytes late in infection. This may explain why, just after the peak parasitemia and initial drop in parasitemia in mice depleted of CD4+ T cells, the parasite invaded reticulocytes whose numbers appeared to be maintained as a result of a sustained reticulocytosis and why a persistent, fulminant parasitemia ensued.
Thus, both CD4-and Thy-i-depleted C57BL/6 mice appeared to compensate for the lack of immune function by mounting a marked and sustained erythropoietic response, with the spleen becoming the major site of erythropoiesis. Spleens from these animals were grossly enlarged, varying in weight from 10 to 15 times that of a normal mouse. We have previously demonstrated that C57BL/6 mice have a superior erythropoietic system and respond to injection with phenylhydrazine with a prompt and marked reticulocytosis (34) . During infection with P. chabaudi AS, susceptible A/J mice develop marked anemia that appears to culminate in their death, whereas resistant C57BL/6 mice suffer only mild anemia (34) . In addition, P. chabaudi AS-resistant mouse strains, such as C57BL/6, develop marked splenomegaly, a trait which is either identical to or closely linked to that conferred by the gene controlling resistance to infection with this murine hemoprotozoan parasite (35, 36) . The importance of an architecturally intact spleen in the control and elimination of an acute malaria infection has been well documented (13, 27) .
In conclusion, our results demonstrate that both CD4+
and CD8+ T cells play a role in acquired immunity to P.
chabaudi AS. Furthermore, the influx of reticulocytes into the blood just after the peak parasitemia may contribute temporarily to limitation of the parasitemia.
